| 中文名称 | 梓醇 |
| 英文名称 | Catalpol |
| CAS号 | 2415-24-9 |
| 分子式 | C15H22O10 |
| 分子量 | 362.33 |
| EINECS号 | 219-324-0 |
| 熔点 | 203-205°C |
| 沸点 | 675.6±55.0 °C(Predicted) |
| 密度 | 1.72±0.1 g/cm3(Predicted) |
| LogP | -4.609 (est) |
| 溶解度 | DMSO(轻微)、乙醇(轻微、超声处理)、甲醇(轻微) |
| 形态 | 固体 |
| 酸度系数(pKa) | 12.79±0.70(Predicted) |
| 颜色 | 白色至类白色 |
| 危险品标志 | Xi |
| 危险类别码 | 36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| RTECS号 | LZ5776816 |
| 海关编码 | 29389090 |
| 毒性 | mouse,LD,intravenous,> 2500mg/kg (2500mg/kg),Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64, Pg. 93, 1968. |
Catalpol (0.1 μg/mL; for 3 days) can induce neuronal differentiation in PC12 cells through activation of the intracellular signal transduction pathway, and promote neurite length.
Catalpol (25-100 mg/kg; intraperitoneal injection; once) treatment clearly reduces blood urea nitrogen, serum creatinine levels and the expression of KIM-1 in renal ischemia/reperfusion-injury (IRI) mice. Catalpol markedly reduces the expression of PI3K, Akt and eNOS levels, and suppresses the TNF-α, IL-1β, IL-6 and IL-10 activities.
| Animal Model: | C57BL/6 mice treated with renal ischemia/reperfusion surgery |
| Dosage: | 25 mg/kg, 50 mg/kg and 100 mg/kg |
| Administration: | Intraperitoneal injection; once |
| Result: | Clearly reduced blood urea nitrogen, serum creatinine levels and the expression of KIM-1 in renal IRI mice. |
用二乙基酮与
1-
氨基乙烯基甲基酮反应制得。